Skip to main content
COFCO BIOTECHNOLOGY CO., LTD. logo

COFCO BIOTECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 000930 ISIN · CNE000000ZR7 LEI · 300300CSR7RNP1P1CP32 Shenzhen Stock Exchange Manufacturing
Filings indexed 2,252 across all filing types
Latest filing 2018-06-15 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000930

About COFCO BIOTECHNOLOGY CO., LTD.

https://www.cofcotech.com

COFCO Biotechnology Co., Ltd. specializes in the deep processing of agricultural products, primarily corn, cassava, and other grains. The company operates as a major producer of fuel ethanol, edible alcohol, and starch-based products. Its portfolio includes a wide range of sweeteners such as fructose and glucose, as well as organic acids like citric acid and lactic acid. Additionally, the firm develops bio-based materials and biochemical products including amino acids and feed additives. Serving diverse sectors such as food and beverage, pharmaceuticals, and renewable energy, the company focuses on technological innovation in biotechnology to enhance resource efficiency and promote sustainable industrial applications. It maintains a significant presence in the global supply chain for bio-based chemicals and ingredients.

Recent filings

Filing Released Lang Actions
董事会关于评估机构的独立性、评估假设前提的合理性、评估方法与评估目的的相关性以及评估定价的公允性的说明
Capital/Financing Update Classification · 95% confidence The document is a statement from the board of directors of 中粮生物化学(安徽)股份有限公司 regarding the independence of the appraisal agency, the reasonableness of appraisal assumptions, the relevance of appraisal methods to the appraisal purpose, and the fairness of the appraisal pricing. It relates to an asset acquisition transaction involving issuance of shares. The document discusses the evaluation report and the appraisal process but does not contain actual financial statements or detailed financial data. It is a formal explanation or opinion about the appraisal report and its fairness, not the appraisal report itself or a full financial report. The document length is short (1518 characters), and it is essentially an announcement or statement about the appraisal related to a capital transaction. This fits best under Capital/Financing Update (CAP) as it concerns a financing-related transaction and appraisal explanation. It is not an Annual Report, Audit Report, or Regulatory Filing. Therefore, the classification is CAP with high confidence.
2018-06-15 Chinese
上海东洲资产评估有限公司关于深圳证券交易所《关于对中粮生物化学(安徽)股份有限公司的重组问询函》之核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed response from an asset evaluation company to an inquiry from the Shenzhen Stock Exchange regarding a major asset restructuring of COFCO Biochemical (Anhui) Co., Ltd. It discusses the evaluation methods used for the assets involved in the restructuring, the rationale behind choosing certain valuation methods, and addresses issues related to asset ownership and legal compliance. The document references a '重组问询函' (restructuring inquiry letter) and provides detailed explanations and assurances about the asset valuation and related legal matters. This content is typical of an Audit Report / Information filing, as it focuses on audit-related opinions, asset valuation methods, compliance with regulatory requirements, and risk assessments related to the restructuring. It is not an announcement, a full annual or interim report, or a presentation, but a formal audit-related response to regulatory inquiries about a restructuring transaction. FY 2017
2018-05-11 Chinese
关于《中粮生物化学(安徽)股份有限公司发行股份购买资产暨关联交易预案》的修订说明
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding revisions to a previously disclosed plan for issuing shares to purchase assets and related party transactions. It includes extensive disclosures about pricing, risk factors, approvals, commitments, and financial data updates related to a restructuring transaction. The document references a prior announcement and regulatory inquiries, and it provides supplementary information and explanations about the transaction and its impact. It is not a full financial report like an Annual Report or Interim Report, nor is it a simple announcement of a report publication. It is a regulatory announcement related to a capital transaction and restructuring, specifically about the issuance of shares to purchase assets and related party transactions. This fits best under the category of Capital/Financing Update (CAP). The document length is 4233 characters, which is substantive and contains detailed information about the transaction, not just a brief notice or certification. Therefore, the classification is CAP with high confidence.
2018-05-11 Chinese
发行股份购买资产暨关联交易预案摘要(修订稿)
Capital/Financing Update Classification · 95% confidence The document is a detailed summary of a plan for issuing shares to purchase assets and related party transactions by 中粮生物化学(安徽)股份有限公司. It includes extensive information about the transaction parties, asset valuation, pricing, issuance details, lock-up periods, and regulatory references such as the China Securities Regulatory Commission and Shenzhen Stock Exchange. The document is lengthy (15,000 characters) and contains substantive financial and transaction data, including asset valuations, issuance pricing, and detailed terms of the transaction. It is clearly a transaction-related filing concerning a major asset acquisition and issuance of shares to finance it. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. It is not an announcement of a report, nor a full annual or interim report, nor a proxy or voting result. Therefore, the appropriate classification is CAP with high confidence.
2018-05-11 Chinese
发行股份购买资产暨关联交易预案(修订稿)
Capital/Financing Update Classification · 95% confidence The document is titled "发行股份购买资产暨关联交易预案(修订稿)" which translates to "Plan for Issuance of Shares to Purchase Assets and Related Party Transaction (Revised Draft)". It details a transaction where the company issues shares to purchase assets from related parties, including transaction pricing, share issuance details, lock-up periods, impact on business and shareholders, and regulatory compliance. The document includes extensive financial data, valuation methods, and legal compliance statements related to a major asset acquisition and related party transaction. This type of document is a detailed transaction proposal and plan for a capital/financing event involving issuance of shares to purchase assets and related party transactions. It is not an earnings release, annual report, or audit report, nor is it a simple announcement or proxy statement. It fits the category of Capital/Financing Update (CAP) because it provides comprehensive information about the issuance of shares to purchase assets and related party transactions, including pricing, valuation, and shareholder impact. The document length (15,000 characters) and content confirm it is a full transaction plan, not just an announcement or summary.
2018-05-11 Chinese
关于公司股票复牌的提示性公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding the resumption of trading of its stock after a suspension due to a major asset restructuring. It details the timeline of the suspension, regulatory inquiries, and the company's responses, as well as the conditions and approvals required for the restructuring to proceed. The document does not contain financial statements or detailed financial data but serves as an update on the status of the company's stock suspension and resumption related to a major asset restructuring. It is an official notice about the stock resumption and ongoing restructuring process rather than the restructuring report or financial report itself. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2018-05-11 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.